MENU
+Compare
TSHA
Stock ticker: NASDAQ
AS OF
Sep 26, 12:07 PM (EDT)
Price
$3.14
Change
+$0.08 (+2.61%)
Capitalization
834.75M

TSHA Taysha Gene Therapies Forecast, Technical & Fundamental Analysis

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more

TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TSHA with price predictions
Sep 24, 2025

TSHA sees its Stochastic Oscillator recovers from oversold territory

On September 24, 2025, the Stochastic Oscillator for TSHA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

TSHA moved above its 50-day moving average on September 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TSHA advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 131 cases where TSHA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TSHA moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TSHA as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TSHA turned negative on September 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSHA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TSHA broke above its upper Bollinger Band on September 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TSHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.356) is normal, around the industry mean (19.844). P/E Ratio (2.698) is within average values for comparable stocks, (54.097). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.112). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (104.167) is also within normal values, averaging (344.917).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TSHA is expected to report earnings to fall 10.89% to -8 cents per share on November 12

Taysha Gene Therapies TSHA Stock Earnings Reports
Q3'25
Est.
$-0.08
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 267.24K shares outstanding, the current market capitalization sits at 834.75M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMAMX88.97N/A
N/A
Fidelity Advisor Stock Sel A
GURCX32.08N/A
N/A
NAA Risk Managed Real Estate C
MXGSX13.23N/A
N/A
Empower Large Cap Growth Instl
MUNDX28.49-0.17
-0.59%
Mundoval
HFETX57.13-0.82
-1.42%
Janus Henderson European Focus T

TSHA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-2.70%
PCVX - TSHA
46%
Loosely correlated
-2.01%
RGNX - TSHA
38%
Loosely correlated
-1.83%
XNCR - TSHA
38%
Loosely correlated
-1.34%
ERAS - TSHA
38%
Loosely correlated
-4.97%
VYGR - TSHA
37%
Loosely correlated
-3.41%
More